| Pharmaceutical active ingredients: |
| CaffeineErgotamine Tartrate |
| Available forms, composition and doses of Caftar: |
| N / A |
| Caftar medical category: |
| Human:Antimigraine preparationsSympatholytic (adrenergic blocking) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02CA52 - Ergotamine, combinations excluding psycholeptics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Quimica y Farmacia |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Cafatine | Caffeine; Ergotamine Tartrate | The Harvard Drug Group |
| Cafergot | Caffeine; Ergotamine Tartrate | Novartis; Alliance Pharmaceuticals; Amdipharm; Invida; Zuellig Pharma |
| Cafergot N | Caffeine; Ergotamine Tartrate | Novartis |
| Cafetrate | Caffeine; Ergotamine Tartrate | Watson Pharmaceuticals |
| Caffox | Caffeine; Ergotamine Tartrate | T.O. Chemicals 1979; Joyson |
| Celetil | Caffeine; Ergotamine Tartrate | Bayer Schering Pharma |
| Degran | Caffeine; Ergotamine Tartrate | Ranbaxy |
| Ercaf | Caffeine; Ergotamine Tartrate | Novartis |
| Ergocaf | Caffeine; Ergotamine Tartrate | Probiomed |
| Ergo-Caff | Caffeine; Ergotamine Tartrate | Probiomed |